Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

8.02
+0.09121.15%
Volume:173.08K
Turnover:1.40M
Market Cap:137.21M
PE:-2.08
High:8.29
Open:8.15
Low:8.00
Close:7.93
52wk High:16.77
52wk Low:7.63
Shares:17.11M
Float Shares:15.72M
Volume Ratio:1.67
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.64
PE(LYR):-2.51

Loading ...

ArcticZymes Wins Key Patent to Drive Expansion in RNA Therapeutics Manufacturing

TIPRANKS
·
Apr 30

Circio Teams With TraffikGene on Non-Viral Delivery for Circular RNA Therapies

TIPRANKS
·
Apr 29

CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation

GlobeNewswire
·
Apr 28

Wave Life Sciences Reports Q1 Results, Advances RNA Pipeline

TIPRANKS
·
Apr 28

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Apr 28

Circio’s circVec Gene Therapy Platform Wins Spotlight at Global ASGCT Meeting

TIPRANKS
·
Apr 28

Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

Dow Jones
·
Apr 28

Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload

GlobeNewswire
·
Apr 27

Press Release: TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University

Dow Jones
·
Apr 27

BUZZ-U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks

Reuters
·
Apr 24

Atrium Therapeutics earns $15 million milestone payment from Bristol Myers Squibb

Reuters
·
Apr 23

Atrium Therapeutics Inc - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties

THOMSON REUTERS
·
Apr 23

Atrium Therapeutics Earns $15 Million Milestone Payment From Bristol Myers Squibb Under Global Cardiovascular Collaboration

THOMSON REUTERS
·
Apr 23

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Clinical, Regulatory, Commercialization Activities From Collaboration

THOMSON REUTERS
·
Apr 23

Perth biotech at cutting edge of the future of medicine

The West Australian
·
Apr 23

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

GlobeNewswire
·
Apr 22

Atrium Therapeutics grants inducement equity awards to seven new hires under Nasdaq rule

Reuters
·
Apr 21

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 21

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

GlobeNewswire
·
Apr 16

Circio clears 2025 reports as funding extends RNA platform runway to 2030

TIPRANKS
·
Apr 16